Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 0 | 12,100 | 0 | 3,135 | 0 |
| Gross Profit | N/A | 12,100 | N/A | 3,135 | N/A |
| Operating Expenses | 16,167 | 16,191 | 13,790 | 5,985 | 11,477 |
| Operating Income | -16,167 | -4,091 | -13,790 | 3,135 | -11,477 |
| Interest Expense | 1,402 | 213 | 130 | 167 | 123 |
| Other Income | -3,722 | -4,793 | -6,340 | 167 | -5,290 |
| Pre-tax Income | -21,291 | -9,097 | -20,260 | 3,135 | -16,890 |
| Net Income Continuous | -21,291 | -9,097 | -20,260 | 3,135 | -16,890 |
| Net Income Discontinuous | N/A | N/A | 577 | -6 | -227 |
| Net Income | $-21,291 | $-9,097 | $-19,683 | $3,135 | $-17,117 |
| EPS Basic Total Ops | -0.33 | -0.14 | -0.35 | -0.35 | -0.32 |
| EPS Basic Continuous Ops | -0.33 | -0.14 | -0.36 | -0.35 | -0.32 |
| EPS Basic Discontinuous Ops | 0.00 | N/A | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.33 | -0.14 | -0.35 | -0.35 | -0.32 |
| EPS Diluted Continuous Ops | -0.33 | -0.14 | -0.36 | -0.35 | -0.32 |
| EPS Diluted Discontinuous Ops | 0.00 | N/A | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-13,137 | $-1,974 | $-11,705 | $-690 | $-9,096 |